OnabotulinumtoxinA for the prevention of chronic migraine in adolescents: the experience of an italian third level headache center

被引：0
|
作者：
Frattale, Ilaria [1 ]
Papetti, Laura [2 ]
Ursitti, Fabiana [2 ]
Sforza, Giorgia [2 ]
Monte, Gabriele [2 ]
Ferilli, Michela Ada Noris [2 ]
Tarantino, Samuela [2 ]
Checchi, Martina Proietti [2 ]
Valeriani, Massimiliano [2 ,3 ]
机构：
[1] Policlin Tor Vergata Fdn Hosp, Dept Neurosci, Child Neurol & Psychiat Unit, Rome, Italy
[2] Bambino Gesu Children Hosp, Dev Neurol, Rome, Italy
[3] Aalborg Univ, Ctr Sensory Motor Interact, Aalborg, Denmark
来源：
CEPHALALGIA | 2023年 / 43卷 / 1supp期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC23-PO-1
引用
收藏
页码：140 / 141
页数：2
相关论文
共 50 条
  • [21] OnabotulinumtoxinA (Botox) for chronic migraine during pregnancy: experience from Hull (UK) headache clinic for 10 years
    Ahmed, Fayyaz
    Wong, Ho-Tin
    Khalil, Modar
    Nasergivehchi, Somayeh
    CEPHALALGIA, 2022, 42 (1_SUPPL) : 134 - 134
  • [22] Acute medications' intake for migraine: a one-year report in patients undergoing first evaluation at a third level Italian headache center
    Bonura, Adriano
    Alesina, Alessandro
    Sapio, Elisabetta
    Brunelli, Nicoletta
    Marcosano, Marilena
    Altamura, Claudia
    Vernieri, Fabrizio
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [23] OnabotulinumtoxinA in Chronic Migraine; Predicting response to treatment based on headache days at baseline
    Buture, Alina
    Ghabeli, Ali J.
    Khalil, Modar
    Ahmed, Fayyaz
    CEPHALALGIA, 2017, 37 : 114 - 114
  • [24] OnabotulinumtoxinA in the treatment of patients with chronic migraine: clinical evidence and experience
    Chiang, Chia-Chun
    Starling, Amaal J.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2017, 10 (12) : 397 - 406
  • [25] Refractory chronic migraine, fatigue and OnabotulinumtoxinA: a clinic setting experience
    Baldacci, Filippo
    Cafalli, Martina
    Lucchesi, Cinzia
    Mazzucchi, Sonia
    Dini, Elisa
    Bonuccelli, Ubaldo
    Gori, Sara
    JOURNAL OF HEADACHE AND PAIN, 2015, 16
  • [26] ONABOTULINUMTOXINA IN CHRONIC MIGRAINE; PREDICTING RESPONSE TO TREATMENT BASED ON HEADACHE DAYS AT BASELINE
    Khalil, M.
    Buture, A.
    Nimeri, R.
    Ahmed, F.
    CEPHALALGIA, 2016, 36 : 118 - 119
  • [27] Headache outcome measures in medically refractory chronic migraine patients treated with OnabotulinumtoxinA
    Susie, Lagrata
    Maha, Ahmed
    Sarah, Miller
    Manjit, Matharu
    JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [28] ONABOTULINUMTOXINA IN CHRONIC MIGRAINE; PREDICTING RESPONSE TO TREATMENT BASED ON HEADACHE DAYS AT BASELINE
    Kalaitzaki, S.
    Papantonakis, E.
    Panagopoulos, G.
    Tsiara, S.
    CEPHALALGIA, 2016, 36 : 118 - 118
  • [29] ONABOTULINUMTOXINA IN CHRONIC MIGRAINE; PREDICTING RESPONSE TO TREATMENT BASED ON HEADACHE DAYS AT BASELINE
    Khalil, M.
    Tanvir, T.
    Buture, A.
    Ahmed, F.
    CEPHALALGIA, 2018, 38 : 91 - 92
  • [30] Multidisciplinary approach to patients with chronic migraine and medication overuse: experience at the Besta Headache Center
    L. Grazzi
    Neurological Sciences, 2013, 34 : 19 - 21
12345